Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOZANTINIB S-MALATE vs CAFFEINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABOZANTINIB S-MALATE vs CAFFEINE: Safety Overview

Metric CABOZANTINIB S-MALATE CAFFEINE
Total FAERS Reports 39,270 3,107
Deaths Reported 4,203 1,667
Death Rate 10.7% 53.7%
Hospitalizations 6,193 983
Average Patient Age 65.0 yrs 43.0 yrs
% Female Patients 29.9% 57.2%
FDA Approval Date Apr 25, 2016 Apr 12, 2000
Manufacturer Exelixis, Inc. Fresenius Kabi USA, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription